Literature DB >> 28333818

Practice Bulletin No. 176: Pelvic Organ Prolapse.

.   

Abstract

Pelvic organ prolapse (POP) is a common, benign condition in women. For many women it can cause vaginal bulge and pressure, voiding dysfunction, defecatory dysfunction, and sexual dysfunction, which may adversely affect quality of life. Women in the United States have a 13% lifetime risk of undergoing surgery for POP (). Although POP can occur in younger women, the peak incidence of POP symptoms is in women aged 70-79 years (). Given the aging population in the United States, it is anticipated that by 2050 the number of women experiencing POP will increase by approximately 50% (). The purpose of this joint document of the American College of Obstetricians and Gynecologists and the American Urogynecologic Society is to review information on the current understanding of POP in women and to outline guidelines for diagnosis and management that are consistent with the best available scientific evidence.

Entities:  

Mesh:

Year:  2017        PMID: 28333818     DOI: 10.1097/AOG.0000000000002016

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Utilization of apical vaginal support procedures at time of inpatient hysterectomy performed for benign conditions: a national estimate.

Authors:  Whitney Trotter Ross; Melanie R Meister; Jonathan P Shepherd; Margaret A Olsen; Jerry L Lowder
Journal:  Am J Obstet Gynecol       Date:  2017-07-14       Impact factor: 8.661

2.  The underutilization of obliterative and constrictive surgery in the surgical treatment of pelvic organ prolapse.

Authors:  Tony Bazi
Journal:  Int Urogynecol J       Date:  2019-06-10       Impact factor: 2.894

3.  Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.

Authors:  Theerarat Yimphong; Teerayut Temtanakitpaisan; Pranom Buppasiri; Chompilas Chongsomchai; Supparaluck Kanchaiyaphum
Journal:  Int Urogynecol J       Date:  2017-08-16       Impact factor: 2.894

4.  Long-term subjective, clinical and sonographic outcomes after native-tissue and mesh-augmented posterior colporrhaphy.

Authors:  Moshe Gillor; Susanne Langer; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2019-03-23       Impact factor: 2.894

5.  The impact on complication rates of delayed routine pessary reviews during the COVID-19 pandemic.

Authors:  Esther R McNeill; James Lucocq; Kirsty Brown; Vanessa Kay
Journal:  Int Urogynecol J       Date:  2022-08-30       Impact factor: 1.932

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.